Immunogenicity of Recombinant Vesicular Stomatitis Vaccine for Ebola-Zaire (rVSV[Delta]G-ZEBOV-GP) for Pre-Exposure Prophylaxis (PREP) in People at Potential Occupational Risk for Ebola Virus Exposure
Condition: Healthy VolunteersIntervention: Drug: rVSVdeltaG-ZEBOV GP (2X 107 pfu/mL)Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Recruiting - verified May 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Ebola | Ebola Vaccine | Infectious Diseases | Occupational Health | Research | Vaccines